Recon: Zimmer to acquire robotics firm Monogram for $177M; WHO adds Gilead’s biannual HIV shot to PrEP guidelines
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- Zimmer to acquire Monogram Technologies for $177 million, boosting robotics portfolio (Reuters)
- Trump's spending bill will likely boost costs for insurers, shrink Medicaid coverage (Reuters)
- Federal Hiring Shake-Up (Again): What the Latest Executive Action and Supreme Court Decision Mean for Industry (FDA Law Blog)
- Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs (The Wall Street Journal)
- The growing influence of vaccine skeptics inside HHS (STAT)
- The FDA commissioner is a gifted talker — but the job is about more than that (STAT)
- Trump’s First Drug Negotiation Move Sparks Combo Medicine Fight (Bloomberg Law)
- GSK seeks FDA nod for expanded use of RSV vaccine in adults (Reuters)
- WHO adds Gilead's twice-yearly injection to global PrEP guidelines (Endpoints)
- European MedTech Keeps Calm Despite US Threats Of 30% Tariffs (MedTech Insight)
- Medtech Will Benefit From Boost To EU’s Quantum Technology Initiative (MedTech Insight)
- US plans 30% tariffs on EU, Mexico (MedTech Dive)
- US plans 35% tariffs on Canada imports (MedTech Dive)
- Ozempic for addiction: How an elite rehab center is using GLP-1s to ‘obliterate’ all kinds of cravings (STAT)
- AstraZeneca posts a pivotal trial win for blood pressure pill behind $1.3B deal (Endpoints)
- FDA declines to approve Ultragenyx's Sanfilippo gene therapy, citing manufacturing issues (Endpoints)
- Takeda’s first-in-class narcolepsy drug succeeds in two registrational studies (Endpoints)
- Merck sends new monthly oral PrEP to Phase 3 after earlier islatravir setback (Endpoints)
- GSK's ViiV expands licensing pact to include long-acting HIV treatment (Endpoints)
- Sun launches alopecia med Leqselvi after Incyte settlement (Fierce Pharma)
- Formulation specialist Azurity to lay off 75 amid plans to sunset Massachusetts plant (Fierce Pharma)
- 11 lessons for health tech startups from one of UpToDate’s creators (STAT)
- Bionic knee developed by MIT researchers gives amputees a new world of motion (STAT)
- Medtronic, Philips Cement New Pact To Embed Next-Gen Tech In Monitoring Platforms (MedTech Insight)
- Study: FDA’s Breakthrough Path Speeds Access, But Raises Safety Questions (MedTech Insight)
- Bivacor Rotary Heart Could Upend The Artificial Heart Market, If It Reaches Its Destination (MedTech Insight)
- FDA Authorizes Use of Fourth ‘Natural’ Food Dye, Gardenia Blue (Food Safety Magazine) (FDA)
- Reports of young children accidentally eating nicotine pouches rose 763% in three years: Study (STAT)
- U.S. drops charges against doctor accused of throwing away Covid shots, selling fake vaccine cards (STAT)
- 25 years ago, I reported on horrifying hospital errors. Here’s what’s changed since then — and what hasn’t (STAT)
- US judge stands by move to block cutting off of Planned Parenthood's Medicaid funding (Reuters)
- CMS proposes covering renal denervation for hypertension (MedTech Dive)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
